Top of this page
Skip navigation, go straight to the content

Patients Clinical Trials

Clinical trials

UCB researchers seek to understand, prevent and treat diseases. Clinical trials involving healthy volunteers and patients play an essential role in the development of new drugs.

UCB is committed to sharing information about our clinical trials in a responsible way, striving to make study results publicly accessible.

This section of the website allows users to:

  • Learn about clinical trials
  • Find out more about UCB’s approach to clinical trials
  • Search for trials that may be of interest
  • Discover results of UCB's clinical trials
  • Read lay summaries of our research results.
image description

About Clinical Trials

image description

What is a clinical trial and how does it work?

For pharmaceutical companies to obtain marketing licenses and make new drugs available to the general public, the safety, quality and efficacy of all potential new drugs must be demonstrated through a series of rigorous clinical trials, also referred to as clinical studies, research studies or medical research.

Clinical trials are generally carried out in a hospital or a medical research centre and involve healthy volunteers or patients. Volunteers or patients are not generally required to stay at the hospital or centre throughout the trial, but the effects of the drug will be closely observed and monitored throughout by highly qualified personnel.


UCB clinical trials policy

UCB is committed to providing the opportunity to patients to make informed decisions about participating in clinical trials.

UCB is committed to increasing transparency relating to the existence and results of sponsored clinical studies. In light of this, we commit to disclosing balanced and accurate information regarding our hypothesis-testing clinical studies, regardless of outcome, to ensure that physicians and patients have access to relevant information from clinical studies.

image description

Access to investigational  drugs

image description
image description

At UCB, we focus on pioneering innovative medicines for people living with severe diseases in immunology, neurology and bone health. Everyday our employees work hard to discover and develop new solutions that allow patients to live a better life of their choosing.

New molecules need to prove their efficacy and safety in clinical studies. The results of these clinical studies allow the regulatory authorities to independently evaluate whether the new medicines should be prescribed. To rigorously assess whether these new medicines work and are safe, we prefer that, where possible, patients have the opportunity to participate in our clinical studies.

Where patients are suffering from serious or immediately life threatening diseases and cannot enroll in a clinical study, if there is enough evidence available in their condition to support its use, and there are no satisfactory alternative treatments available, we will consider allowing early access to certain new medicines under conditions of strict supervision to monitor safety and the patient’s response.

Our corporate position and principles for considering early access to new medicines are described in our Policy, which can be accessed here.

For more information on early access programs please contact us:


Trial information search

The first stage in which humans may participate in the study of a new drug is Phase I.

Participants in Phase II and III are patients with the medical condition for which the new medicine is being tested.

Volunteers and patients take part in clinical trials on a voluntary basis only. You may only participate in a clinical trial if you have given us your informed consent and have confirmed that you have received and fully understand information about the trial. You are also free to withdraw from a trial at any time.

To find a clinical trial that you may wish to participate in, please visit provides regularly updated information about publicly and privately supported clinical research in human volunteers. gives you information about a trial's purpose, who may participate, locations, and phone numbers for more details. The information provided on should be used in conjunction with advice from health care professionals.

If you specifically wish to take part in a UCB trial, please add UCB to the search function on the home page.

Alternatively; please phone UCB Cares (US): +1 844-599-2273

image description

Trial results search

Information on UCB’s clinical studies can be found on this website through the section Our Clinical Studies and also through the independent registries and is a registry of federally and privately supported clinical trials conducted in the United States and around the world. The database gives information about a trial's purpose, criteria for participation, locations, contact information and basic results for marketed products.

The EU Clinical Trials Register allows to search for protocol and results information on:

  • interventional clinical trials that are conducted in the European Union (EU) and the European Economic Area (EEA)
  • clinical trials conducted outside the EU / EEA that are linked to European paediatric-medicine development.